Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Inhaled GW642444M in Persistent Asthma
NCT00381667Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of vilanterol in asthma (5 arms), sponsored by GSK. Primary endpoints: Mean change from baseline FEV1, Adverse events and 5 more. Started Aug 2006; status: completed.
02
Drugs
vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00381667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381667.